Literature DB >> 12808022

Consequences of nonadaptive alterations in cancer.

Alexander Kamb1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12808022      PMCID： PMC194870          DOI： 10.1091/mbc.e02-11-0732

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN： 1059-1524            Impact factor:   4.138


× No keyword cloud information.
  30 in total

1.  Haplotype variation and linkage disequilibrium in 313 human genes.

Authors:  J C Stephens; J A Schneider; D A Tanguay; J Choi; T Acharya; S E Stanley; R Jiang; C J Messer; A Chew; J H Han; J Duan; J L Carr; M S Lee; B Koshy; A M Kumar; G Zhang; W R Newell; A Windemuth; C Xu; T S Kalbfleisch; S L Shaner; K Arnold; V Schulz; C M Drysdale; K Nandabalan; R S Judson; G Ruano; G F Vovis
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

2.  14-3-3 proteins mediate an essential anti-apoptotic signal.

Authors:  S C Masters; H Fu
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

3.  The mutation rate and cancer.

Authors:  I P Tomlinson; M R Novelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 4.  Asparaginase revisited.

Authors:  R L Capizzi
Journal:  Leuk Lymphoma       Date:  1993

Review 5.  Dosage compensation in Drosophila.

Authors:  B S Baker; M Gorman; I Marín
Journal:  Annu Rev Genet       Date:  1994       Impact factor: 16.830

6.  Human haploinsufficiency--one for sorrow, two for joy.

Authors:  E Fisher; P Scambler
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

7.  Genomic profiling of drug sensitivities via induced haploinsufficiency.

Authors:  G Giaever; D D Shoemaker; T W Jones; H Liang; E A Winzeler; A Astromoff; R W Davis
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

8.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Environmental stress and mutational load in diploid strains of the yeast Saccharomyces cerevisiae.

Authors:  K Szafraniec; R H Borts; R Korona
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205
View more
  12 in total

1.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

Review 2.  Cell-based therapy for neural disorders--anticipating challenges.

Authors:  Arlene Y Chiu; Mahendra S Rao
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

3.  Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1.

Authors:  Dong Hoon Shin; Ji-Youn Han; Sun Ha Kim; Minyoung Choi; Young-Ki Bae; Chungyong Han; Beom K Choi; Sang Soo Kim
Journal:  Oncogene       Date:  2021-11-06       Impact factor: 9.867

4.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

5.  A mutant allele of the transcription factor IIH helicase gene, RAD3, promotes loss of heterozygosity in response to a DNA replication defect in Saccharomyces cerevisiae.

Authors:  Michelle S Navarro; Liu Bi; Adam M Bailis
Journal:  Genetics       Date:  2007-05-04       Impact factor: 4.562

6.  The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.

Authors:  Mayuko Furuta; Ken-ichi Kozaki; Kousuke Tanimoto; Shinji Tanaka; Shigeki Arii; Teppei Shimamura; Atsushi Niida; Satoru Miyano; Johji Inazawa
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

7.  Challenges in pharmacology of anti-cancer drugs - the search for addictions.

Authors:  Olivier Feron
Journal:  Front Pharmacol       Date:  2010-09-20       Impact factor: 5.810

8.  Systems biology modeling reveals a possible mechanism of the tumor cell death upon oncogene inactivation in EGFR addicted cancers.

Authors:  Jian-Ping Zhou; Xin Chen; Shan Feng; Shi-Dong Luo; You-Li Pan; Lei Zhong; Pan Ji; Ze-Rong Wang; Shuang Ma; Lin-Li Li; Yu-Quan Wei; Sheng-Yong Yang
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 9.  Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils.

Authors:  Davide Torti; Livio Trusolino
Journal:  EMBO Mol Med       Date:  2011-09-23       Impact factor: 12.137

10.  Oncogene addiction: resetting the safety switch?

Authors:  Yulin Li; Peter S Choi; Dean W Felsher
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.